Observations placeholder
Vincristine Sulfate
Identifier
020370
Type of Spiritual Experience
Background
A description of the experience
Vincristine, also known as leurocristine and marketed under the brandname Oncovin among others, is a chemotherapy medication used to treat a number of types of cancer. This includes acute lymphocytic leukemia, acute myeloid leukemia, Hodgkin's disease, neuroblastoma, and small cell lung cancer among others. It is given intravenously
Most people experience some side effects from vincristine treatment. Commonly it causes a change in sensation, hair loss, constipation, difficulty walking, and headaches. Serious side effects may include neuropathic pain, lung damage, or low blood white cells. It will likely cause harm to an infant if given during pregnancy. It works by stopping cells from dividing properly.
On Jan, 01, 2017 8,340 people reported to have side effects when taking Vincristine Sulfate. Among them, 14 people (0.17%) have Hallucination
Time on Vincristine sulfate when people have Hallucination :
n/a |
Gender of people who have Hallucination when taking Vincristine sulfate :
Female | Male | |
Hallucination | 66.67% | 33.33% |
Age of people who have Hallucination when taking Vincristine sulfate :
0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
Hallucination | 0.00% | 0.00% | 28.57% | 0.00% | 0.00% | 0.00% | 28.57% | 42.86% |
On Feb, 18, 2016: 5,904 people reported to have side effects when taking Vincristine sulfate. Among them, 90 people (1.52%) have Death.
Time on Vincristine sulfate when people have Death :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Death | 33.33% | 44.44% | 16.67% | 0.00% | 5.56% | 0.00% | 0.00% |
Gender of people who have Death when taking Vincristine sulfate :
Female | Male | |
Death | 42.86% | 57.14% |
Age of people who have Death when taking Vincristine sulfate :
0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
Death | 3.39% | 3.39% | 3.39% | 3.39% | 11.86% | 8.47% | 13.56% | 52.54% |
Top conditions involved for these people :
- B-cell lymphoma (12 people, 13.33%)
- Burkitt's lymphoma (10 people, 11.11%)
- Acute lymphocytic leukaemia (9 people, 10.00%)